Clinical Experience with Adalimumab in a Multicenter Swiss Cohort of Patients with Crohn’s Disease

By  

Digestion, Vol. 81, Iss. 2, 2010-01 ,pp. : 78-85

Karger

Access to resources Recommend Favorite

Long-Term Clinical Remission in Biologically Naïve Crohn’s Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab

By  

Case Reports in Gastroenterology, Vol. 10, Iss. 2, 2016-06 ,pp. : 283-291

Karger

Access to resources Recommend Favorite

Incidence, Clinical Characteristics, Long-Term Course, and Comparison of Progressive and Nonprogressive Cases of Aphthous-Type Crohn's Disease: A Single-Center Cohort Study

By  

Digestion, Vol. 87, Iss. 4, 2013-06 ,pp. : 262-268

Karger

Access to resources Recommend Favorite

Therapeutic Strategy for Crohn's Disease with a Loss of Response to Infliximab: A Single-Center Retrospective Study

By  

Digestion, Vol. 91, Iss. 1, 2015-01 ,pp. : 50-56

Karger

Access to resources Recommend Favorite

Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study

By Steenholdt Casper   Molazahi Akbar   Ainsworth Mark Andrew   Brynskov Jørn   Thomsen Ole Østergaard   Seidelin Jakob Benedict  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 5, 2012-05 ,pp. : 518-527

Informa Healthcare

Access to resources Recommend Favorite